Biotage AB – changes in number of shares and votes
As previously announced, the shareholders resolved at the Annual General Meeting held on 25 April 2013 to withdraw 3,394,375 shares, which had been repurchased under the company’s re-purchase program. Following withdrawal of these shares the number of outstanding shares and votes amounts to 69,861,330 as of 31 May 2013.
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, firstname.lastname@example.org
Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08.00 on 31 May 2013.
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 463 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com